|
Diabetes, Vol 44, Issue 1 90-97, Copyright © 1995 by American Diabetes Association
Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients
C Bjorbaek, TA Vik, SM Echwald, PY Yang, H Vestergaard, JP Wang, GC Webb, K Richmond, T Hansen, RL Erikson and al. et
Steno Diabetes Center, Copenhagen, Denmark.
Complementary DNA encoding three catalytic subunits of protein phosphatase
1 (PP1 alpha, PP1 beta, and PP1 gamma) and the insulin-stimulated protein
kinase 1 (ISPK-1) was analyzed for variations in the coding regions related
to insulin-resistant glycogen synthesis in skeletal muscle of 30 patients
with non-insulin-dependent diabetes mellitus (NIDDM). The human ISPK-1 cDNA
was cloned from T-cell leukemia and placental cDNA libraries and mapped to
the short arm of the human X chromosome. Single-strand conformation
polymorphism (SSCP) analysis identified a total of six variations in the
coding regions of the PP1 genes: two in PP1 alpha at codons 90 and 255; one
in PP1 beta at codon 67; and three in PP1 gamma at codons 11,269, and 273,
respectively. All were, however, silent single nucleotide substitutions.
SSCP analysis of the ISPK-1 gene identified one silent polymorphism at
codon 266 and one amino acid variant at codon 38 (Ile-->Ser). This
variant was primarily found in one male NIDDM patient. This subject,
however, did not exhibit an impairment of muscle insulin-stimulated
glycogen synthase activation. No significant differences were found in mRNA
levels in muscle of the four genes between 15 NIDDM patients and 14 healthy
subjects. Our findings suggest that 1) genetic abnormalities in the coding
regions of PP1 alpha, PP1 beta, PP1 gamma, and ISPK-1 are unlikely to be
frequently occurring causes of the reduced insulin-stimulated activation of
the glycogen synthesis in muscle from the analyzed group of NIDDM patients;
2) the mRNA levels of PP1 alpha, PP1 beta, PP1 gamma, and ISPK-1 are normal
in muscle from the NIDDM patients; and 3) putative inherited defects in
insulin-stimulated activation of muscle glycogen synthesis in patients with
insulin-resistant NIDDM may be located further upstream of ISPK-1 in the
insulin action cascade.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Cabeza, Z. Li, C. Schulz, E. Kremmer, S. Massberg, A. Bultmann, and M. Gawaz
Surface Expression of Collagen Receptor Fc Receptor-{gamma}/Glycoprotein VI Is Enhanced on Platelets in Type 2 Diabetes and Mediates Release of CD40 Ligand and Activation of Endothelial Cells
Diabetes,
August 1, 2004;
53(8):
2117 - 2121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. El-Haschimi, S. D. Dufresne, M. F. Hirshman, J. S. Flier, L. J. Goodyear, and C. Bjorbaek
Insulin Resistance and Lipodystrophy in Mice Lacking Ribosomal S6 Kinase 2
Diabetes,
June 1, 2003;
52(6):
1340 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zeniou, T. Ding, E. Trivier, and A. Hanauer
Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning
Hum. Mol. Genet.,
November 1, 2002;
11(23):
2929 - 2940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Hanauer and I D Young
Coffin-Lowry syndrome: clinical and molecular features
J. Med. Genet.,
October 1, 2002;
39(10):
705 - 713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Dufresne, C. Bjørbæk, K. El-Haschimi, Y. Zhao, W. G. Aschenbach, D. E. Moller, and L. J. Goodyear
Altered Extracellular Signal-Regulated Kinase Signaling and Glycogen Metabolism in Skeletal Muscle from p90 Ribosomal S6 Kinase 2 Knockout Mice
Mol. Cell. Biol.,
January 1, 2001;
21(1):
81 - 87.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. M. Moxham, A. Tabrizchi, R. J. Davis, and CraigC. Malbon
jun N-terminal Kinase Mediates Activation of Skeletal Muscle Glycogen Synthase by Insulin in Vivo
J. Biol. Chem.,
November 29, 1996;
271(48):
30765 - 30773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, C. Bjorbak, and D. E. Moller
Regulation and Interaction of pp90rsk Isoforms with Mitogen-activated Protein Kinases
J. Biol. Chem.,
November 22, 1996;
271(47):
29773 - 29779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bjørbæk, Y. Zhao, and D. E. Moller
Divergent Functional Roles for p90[IMAGE] Kinase Domains
J. Biol. Chem.,
August 11, 1995;
270(32):
18848 - 18852.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|